Table 2 CD4 and RNA at initiation and at 8 month (or last visit) by levels of ART adherence (N = 60)
Attended all clinic visits (n = 40) | Attended some clinic visits, including 8 month visit (n = 13) | Stopped ART before 8 month visit (n = 7) | Total (n = 60) | |
|---|---|---|---|---|
CD4 Count | ||||
Initiation CD4 Count: n(%) | 38 (95%) | 13 (100%) | 5 (71%) | 56 (93%) |
Median (IQR) | 219 (145,306) | 213 (84,323) | 160 (124,216) | 215 (129,301) |
Follow-up CD4 Count: n(%) | 38 (95%) | 13 (100%) | 5 (71%) | 56 (93%) |
Median (IQR) | 316 (194,384) | 308 (113,360) | 123 (100,253) | 293 (154,382) |
p = 0.02 | p = 0.03 | p = 0.5 | ||
Viral Load (VL) | ||||
Initiation VL: n(%) | 35 (88%) | 12 (92%) | 4 (57%) | 51 (85%) |
RNA <1000: n(%) | 16 (46%) | 4 (33%) | 1 (25%) | 21 (41%) |
Median (IQR) | 5840 (61,156000) | 7440 (114,872779) | 341259 (75232,911102) | 12000 (75,268000) |
Final VL: n(%) | 37 (93%) | 12 (92%) | 4 (57 %) | 53 (88%) |
RNA <1000: n(%) | 31 (84%)* | 7 (58%)* | 1 (25%)* | 39 (74%) |
p < 0.001 | p = 0.4 | p = 1.0 | ||
Median (IQR) | 50 (50,400)** | 275 (50,7022)** | 3750 (907,153000)** | 64 (50,1030) |